ArticleBiosafety and health2020
A strategy to prevent future epidemics similar to the 2019-nCoV outbreak.
Article in Biosafety and health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
64 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Meta-analysis to explain unknown causes of the origins of SARS-COV-2.Environmental research · 2022Pooled it
- Wildlife Trade and Genetic Basis of Disease Susceptibility: A Review.International journal of immunogenetics · 2026Review
- Stakeholder identification and prioritization of barriers to One Health implementation in Ghana's zoonotic disease surveillance and response system: a sequential mixed-methods study.BMC health services research · 2026Article
- Faster than Virus: The Physics of Pandemic Prediction.Infectious disease reports · 2026Article
- A diagnostic void in the Congo Basin: proposing a zoonotic orthopoxvirus as the cause of a hemorrhagic fever outbreak and a call for equitable health security.Infectious diseases of poverty · 2025Article
- Communicating wastewater-based surveillance data to drive action.Journal of water and health · 2025Review
- Selecting Sites for Strategic Surveillance of Zoonotic Pathogens: A Case Study in Panamá.EcoHealth · 2025Article
- Virome landscape of wild rodents and shrews in Central China.Microbiome · 2025Article
- Article
- Integrating animal welfare into the WHO pandemic treaty: a thematic analysis of civil society perspectives and comparison with treaty drafting.Frontiers in veterinary science · 2024Article
- Strengthening coordination and collaboration of one health approach for zoonotic diseases in Africa.One health outlook · 2023Article
- Perceptions of COVID-19 origins and China's wildlife policy reforms.Global ecology and conservation · 2023Article
- Global governance for pandemic prevention and the wildlife trade.The Lancet. Planetary health · 2023Review
- Sources, diffusion and prediction in COVID-19 pandemic: lessons learned to face next health emergency.AIMS public health · 2023Review
- Synergistic fight against future pandemics: Lessons from previous pandemics.Le infezioni in medicina · 2023Review
- Surveillance of emerging infectious diseases for biosecurity.Science China. Life sciences · 2022Review
- Human-Altered Landscapes and Climate to Predict Human Infectious Disease Hotspots.Tropical medicine and infectious disease · 2022Article
- Serology as a Tool to Assess Infectious Disease Landscapes and Guide Public Health Policy.Pathogens (Basel, Switzerland) · 2022Review
- Microbial ecology and evolution is key to pandemics: using the coronavirus model to mitigate future public health challenges.Heliyon · 2022Review
- Averting wildlife-borne infectious disease epidemics requires a focus on socio-ecological drivers and a redesign of the global food system.EClinicalMedicine · 2022Review
4 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
A novel bat-origin coronavirus emerged in Wuhan, China in December 2019 and continues to spread across China and the world. At the time of writing, a massive global response has been implemented to control the disease as it spreads from person to person. Yet the high-risk human-wildlife interactions and interfaces that led to the emergence of SARS-CoV and of 2019-nCoV continue to exist in emerging disease hotspots globally. To prevent the next epidemic and pandemic related to these interfaces, we call for research and investment in three areas: 1) surveillance among wildlife to identify the high-risk pathogens they carry; 2) surveillance among people who have contact with wildlife to identify early spillover events; and 3) improvement of market biosecurity regarding the wildlife trade. As the emergence of a novel virus anywhere can impact the furthest reaches of our connected world, international collaboration among scientists is essential to address these risks and prevent the next pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.